Location History:
- Boulder, CO (US) (2001)
- Boulder, CA (US) (2006)
Company Filing History:
Years Active: 2001-2006
Title: The Innovations of Daniel Peter Claude McGee
Introduction
Daniel Peter Claude McGee is a notable inventor based in Boulder, California. He has made significant contributions to the field of biochemistry, particularly in the development of oligonucleotides. With a total of two patents to his name, McGee's work has implications for protein synthesis and pharmaceutical applications.
Latest Patents
McGee's latest patents include "Oligonucleotides containing 2'-O-modified purines" and "Process for the preparation of 2'-O-alkyl-guanosine, cytidine, and uridine phosphoramidites." The first patent describes compounds that contain purine nucleotides with various moieties at the 2' position, which are useful for modulating protein synthesis. The second patent outlines processes for preparing 2'-O-alkylated nucleoside phosphoramidites, detailing the steps of alkylating nucleoside precursors and adding suitable blocking groups.
Career Highlights
McGee is currently employed at Isis Pharmaceuticals, Inc., where he continues to innovate in the field of nucleic acid chemistry. His work has been instrumental in advancing the understanding and application of modified nucleotides in therapeutic contexts.
Collaborations
Throughout his career, McGee has collaborated with notable colleagues such as Phillip Dan Cook and Charles John Guinosso. These partnerships have contributed to the successful development of his patented technologies.
Conclusion
Daniel Peter Claude McGee's contributions to the field of biochemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the scientific community and the development of new therapeutic strategies.